Drugs belonging to class 'Janus kinase (JAK) inhibitor'

See adverse reactions attributed to class 'Janus kinase (JAK) inhibitor'

Drug NameCompare
Baricitinibcompare
Ruxolitinibcompare
Tofacitinibcompare
Upadacitinib hemihydratecompare

 

Adverse reactions attributed to entire drug class 'Janus kinase (JAK) inhibitor'

Please login to view adverse reactions

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric